TA
Trevor Allred Oppenheimer Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
15
Avg Return
Past Year
Past Year
22%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past Year
Positive
93.3%
Neutral
6.7%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Healthcare
Healthcare
Biotechnology
| Stock | Rating | Price Target |
Upside Downside |
Ratings 1 Year |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Perform
Downgraded
| – | – | 2 | -26% |
0
%
| 5 Mar ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $277 |
20%
upside
| 5 | +16% |
0
%
| 27 Feb ‘26 1 month ago |
|
|
|
Outperform
Maintained
| $81 |
11%
upside
| 2 | -3.1% |
0
%
| 25 Feb ‘26 2 months ago |
|
|
|
Outperform
Initiated
| $75 |
214%
upside
| 1 | -9% |
0
%
| 7 Jan ‘26 3 months ago |
|
|
|
Outperform
Initiated
| $18 |
44%
upside
| 1 | +23% |
0
%
| 7 Jan ‘26 3 months ago |
|
|
|
Outperform
Maintained
| $80 |
150%
upside
| 2 | +50% |
0
%
| 23 Sep ‘25 7 months ago |
|
|
|
Outperform
Initiated
| $85 |
31%
downside
| 1 | +132% |
0
%
| 9 Sep ‘25 7 months ago |
|
|
|
Outperform
Initiated
| $35 |
48%
upside
| 1 | +21% |
0
%
| 11 Aug ‘25 8 months ago |
|